Cost–consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: The potential impact of different cross-protection profiles

S Capri, R Gasparini, D Panatto, N Demarteau - Gynecologic oncology, 2011 - Elsevier
OBJECTIVES: Two human papillomavirus (HPV) vaccines are currently available: a bivalent
HPV-16/18 and a quadrivalent HPV-6/11/16/18 vaccine. The vaccines may have different …
被引用次数：38 相关文章

Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles.

S Capri, R Gasparini, D Panatto… - Gynecologic …, 2011 - europepmc.org
Objectives Two human papillomavirus (HPV) vaccines are currently available: a bivalent
HPV-16/18 and a quadrivalent HPV-6/11/16/18 vaccine. The vaccines may have different …

Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles

S Capri, R Gasparini, D Panatto… - Gynecologic …, 2011 - pubmed.ncbi.nlm.nih.gov
Objectives Two human papillomavirus (HPV) vaccines are currently available: a bivalent
HPV-16/18 and a quadrivalent HPV-6/11/16/18 vaccine. The vaccines may have different …

Cost–consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: The potential impact of different cross-protection profiles

S Capri, R Gasparini, D Panatto, N Demarteau - Gynecologic Oncology, 2011 - infona.pl
Two human papillomavirus (HPV) vaccines are currently available: a bivalent HPV-16/18
and a quadrivalent HPV-6/11/16/18 vaccine. The vaccines may have different sustained-and …

Cost–consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: The potential impact of different cross-protection profiles

S Capri, R Gasparini, D Panatto… - Gynecologic …, 2011 - gynecologiconcology-online.net
Objectives Two human papillomavirus (HPV) vaccines are currently available: a bivalent
HPV-16/18 and a quadrivalent HPV-6/11/16/18 vaccine. The vaccines may have different …

Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles.

S Capri, R Gasparini, D Panatto, N Demarteau - 2011 - cabidigitallibrary.org
Objectives: Two human papillomavirus (HPV) vaccines are currently available: a bivalent
HPV-16/18 and a quadrivalent HPV-6/11/16/18 vaccine. The vaccines may have different …